PHASE-I TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, EPIRUBICIN AND 5-FLUOROURACIL (CEF) FOR STAGE-II BREAST-CANCER

被引：0
|
作者：
JONES, SE
MENNEL, RG
PETERS, GN
WESTRICK, MA
BROOKS, BD
KNOX, SM
MCGUFFEY, P
机构：
来源：
INVESTIGATIONAL NEW DRUGS | 1988年 / 6卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：195 / 198
页数：4
相关论文
共 50 条
  • [31] Effects on blood coagulation of adjuvant CNF (Cyclophosphamide, Novantrone, 5-Fluorouracil) chemotherapy in stage II breast cancer patients
    Pectasides, D
    Tsavdaridis, D
    Aggouridaki, C
    Tsavdaridou, V
    Visvikis, A
    Tsatalas, K
    Fountzilas, G
    ANTICANCER RESEARCH, 1999, 19 (4C) : 3521 - 3526
  • [32] PHASE I/II TRIAL OF DIPYRIDAMOLE, 5-FLUOROURACIL, LEUKOVORIN, AND MITOXANTRONE IN METASTATIC BREAST-CANCER
    BUDD, GT
    HERZOG, P
    BUKOWSKI, RM
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (04) : 283 - 287
  • [33] THE CARDIOPROTECTOR ADR-529 AND HIGH-DOSE EPIRUBICIN GIVEN IN COMBINATION WITH CYCLOPHOSPHAMIDE, 5-FLUOROURACIL, AND TAMOXIFEN - A PHASE-I STUDY IN METASTATIC BREAST-CANCER
    SORENSEN, B
    BASTHOLT, L
    MIRZA, MR
    GJEDDE, SB
    JAKOBSEN, P
    MOURIDSEN, HT
    ROSE, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 (05) : 439 - 443
  • [34] CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE METHOTREXATE AND FLUOROURACIL (CMF) FOR BREAST-CANCER
    HOWELL, A
    BUSH, H
    GEORGE, WD
    HOWAT, JMT
    CROWTHER, D
    SELLWOOD, RA
    RUBENS, RD
    HAYWARD, JL
    BULBROOK, RD
    FENTIMAN, IS
    CHAUDARY, M
    BRITISH JOURNAL OF CANCER, 1984, 50 (02) : 253 - 253
  • [35] ADJUVANT THERAPY OF STAGE-II BREAST-CANCER
    CARBONE, PP
    CANCER, 1990, 65 (09) : 2148 - 2154
  • [36] PHASE-I TRIAL OF INTRAPERITONEAL CHEMOTHERAPY WITH 5-FLUOROURACIL AND CITROVORUM FACTOR
    BUDD, GT
    SCHREIBER, MJ
    STEIGER, E
    BUKOWSKI, RM
    WEICK, JK
    INVESTIGATIONAL NEW DRUGS, 1986, 4 (02) : 155 - 158
  • [37] PHASE-I-II EVALUATION OF COMBINATION CYCLOPHOSPHAMIDE, 5-FLUOROURACIL, HEXAMETHYLMELAMINE, AND PREDNISONE IN ADVANCED BREAST-CANCER
    CHANG, YC
    FALKSON, G
    TORMEY, DC
    CROWLEY, J
    CANCER CLINICAL TRIALS, 1981, 4 (04) : 377 - 380
  • [38] CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer - A phase III randomized multicenter study
    Ron, IG
    Wigler, N
    Borovik, R
    Brufman, G
    Rizel, S
    Shani, A
    Brenner, J
    Farbstein, H
    Dale, A
    Inbar, MJ
    Brenner, HJ
    Chaitchik, S
    Catane, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (04): : 323 - 327
  • [39] ADJUVANT TAMOXIFEN IN POSTMENOPAUSAL STAGE-II BREAST-CANCER 5 YEARS ON
    MIKL, J
    CZERWENKA, K
    SALZER, H
    SPONA, J
    AIGINGER, P
    KUBISTA, E
    SEVELDA, P
    STAFFEN, A
    ZIELINSKI, CC
    LANCET, 1990, 335 (8688): : 541 - 541
  • [40] COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, MITOXANTRONE AND 5-FLUOROURACIL IN PATIENTS WITH METASTATIC BREAST-CANCER
    YAP, HY
    ESPARZA, L
    BLUMENSCHEIN, GR
    HORTOBAGYI, GN
    BODEY, GP
    CANCER TREATMENT REVIEWS, 1983, 10 : 53 - 55
12345